WETS
PRME icon

Wealth Enhancement Trust Services’s Prime Medicine PRME Stock Holding History

Wealth Enhancement Trust Services’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11 Buy
+3
New +$10 ﹤0.01% 1517

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
CCC
Chelsea Counsel Company Los Angeles, California $236M AUM 51.76% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Wealth Enhancement Trust Services's PRME Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Prime Medicine (PRME) in Q2 2026: 3 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

98 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Wealth Enhancement Trust Services held 3 shares of Prime Medicine worth $11 as of Q2 2026.
  • Prime Medicine was a new Wealth Enhancement Trust Services position in Q2 2026.
  • Prime Medicine made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1517 holding.
  • 98 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.